<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>International Journal of Radiation Research</title>
<title_fa>نشریه پرتو پژوه</title_fa>
<short_title>Int J Radiat Res</short_title>
<subject>Basic Sciences</subject>
<web_url>http://ijrr.com</web_url>
<journal_hbi_system_id>79</journal_hbi_system_id>
<journal_hbi_system_user>journal79</journal_hbi_system_user>
<journal_id_issn>2322-3243</journal_id_issn>
<journal_id_issn_online>2345-4229</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/ijrr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1392</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2013</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<volume>11</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>RapidArc: Initial experience in high grade glioma </title>
	<subject_fa>Radiation Oncology</subject_fa>
	<subject>Radiation Oncology</subject>
	<content_type_fa>تحقيق بديع</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;&lt;strong&gt;Background:&lt;/strong&gt; Identify the optimal technique of radiotherapy for patients with high grade glioma. Our initial year of experience with RapidArc radiation therapy. &lt;strong&gt;Materials and Methods:&lt;/strong&gt; Planning CT scans of 50 patients with grade IV glioma were reviewed and three plan sets by 3D Conformal Radiotherapy (3DCRT), Intensity Modulated Radiotherapy (IMRT) and Rapid Arc (RA) were generated and the plans were compared. &lt;strong&gt;Results:&lt;/strong&gt; Planning target Volume (PTV) coverage is comparable. However IMRT and RA give better sparing of critical structures. Treatment time and Monitor Units (MU) for Rapid Arc is much less compared to IMRT. &lt;strong&gt;Conclusion:&lt;/strong&gt; If PTV is near to the Organs at Risk (OAR), then IMRT gives good result in comparison to 3DCRT plans. Rapid Arc is faster than IMRT and 3DCRT for same dose prescription to PTV and constraints of OAR.&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>High grade glioma, radiotherapy planning, organ at risk, planning target volume, 3D conformal radiotherapy, intensity modulated radiotherapy, Rapid Arc</keyword>
	<start_page>203</start_page>
	<end_page>206</end_page>
	<web_url>http://ijrr.com/browse.php?a_code=A-10-1-474&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>B.</first_name>
	<middle_name></middle_name>
	<last_name>Goswami</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>brijeshccs@rediffmail.com</email>
	<code>790031947532846007524</code>
	<orcid>790031947532846007524</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Radiation Oncology, Apollo Gleneagles Cancer Hospital, Kolkata, India</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>S.</first_name>
	<middle_name></middle_name>
	<last_name>Mitra</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>790031947532846007525</code>
	<orcid>790031947532846007525</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, Apollo Gleneagles Cancer Hospital, Kolkata, India</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>S.</first_name>
	<middle_name></middle_name>
	<last_name>Banerjee</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>790031947532846007526</code>
	<orcid>790031947532846007526</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, Apollo Gleneagles Cancer Hospital, Kolkata, India</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>A.</first_name>
	<middle_name></middle_name>
	<last_name>Shiva B</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>790031947532846007527</code>
	<orcid>790031947532846007527</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, Apollo Gleneagles Cancer Hospital, Kolkata, India</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>P.</first_name>
	<middle_name></middle_name>
	<last_name>Nagendran</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>790031947532846007528</code>
	<orcid>790031947532846007528</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, Apollo Gleneagles Cancer Hospital, Kolkata, India</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>P.</first_name>
	<middle_name></middle_name>
	<last_name>Kumari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>790031947532846007529</code>
	<orcid>790031947532846007529</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, Apollo Gleneagles Cancer Hospital, Kolkata, India</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>P.</first_name>
	<middle_name></middle_name>
	<last_name>Goswami</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>790031947532846007530</code>
	<orcid>790031947532846007530</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Medical Physicist, Department of Radiotherapy, Command Hospital, Lucknow, India</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>A.</first_name>
	<middle_name></middle_name>
	<last_name>Chakraborty</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>790031947532846007531</code>
	<orcid>790031947532846007531</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, Apollo Gleneagles Cancer Hospital, Kolkata, India</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>S.</first_name>
	<middle_name></middle_name>
	<last_name>Mukherjee</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>790031947532846007532</code>
	<orcid>790031947532846007532</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, Apollo Gleneagles Cancer Hospital, Kolkata, India</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
